PARP1-IN-27
PARP1-IN-27 (Compound 9B) is the inhibitor for PARP1 and PARP2, with IC50 of 2.53 nM and 6.45 nM in cell SUM149PT. PARP1-IN-27 inhibits the proliferation of BRCA-mutated cancer cells SUM149PT, HCC1937 and Capan-1, with IC50 of 0.62, 1.91 and 4.26 μM respectively. PARP1-IN-27 aggravates DNA double-strand breaks, increases ROS generation, arrests cell cycle at G2/M phase, and induces apoptosis in SUM149PT[1].
Product Specifications
UNSPSC
12352005
Target
Apoptosis; PARP; Reactive Oxygen Species (ROS)
Type
Reference compound
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; Epigenetics; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/parp1-in-27.html
Smiles
O=C1C(C2=CC=CC(OC)=C2)=CC3=CC(F)=CC(C(N)=O)=C3O1
Molecular Formula
C17H12FNO4
Molecular Weight
313.28
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MAPKAPK3 (Mitogen-activated Protein Kinase-activated Protein Kinase 3, MAP Kinase-activated Protein Kinase 3, MAPK-activated Protein Kinase 3, MAPKAP Kinase 3, MAPKAPK-3, Chromosome 3p Kinase, 3pK) (AP) discontinued
Cy3 Linked Monoclonal Antibody to Cross Linked NTelopeptide Of Type I Collagen (NTXI)